In a prospective study enrolling 56 intermediate grade prostate cancer patients before prostatectomy, PSMA PET was found to be accurate in detecting intraprostatic lesions of ISUP ≥ 2. This evidence concerns the gene FOLH1 and Familial prostate cancer.